Chronic skin diseases such as psoriasis (itchy, scaly skin patches), eczema (long-term skin allergy), and hidradenitis ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing ...

Recently, VYNE has concentrated on advancing its InhiBET™ portfolio, especially two candidates: repibresib gel, a topical treatment for nonsegmental vitiligo (a skin depigmentation disorder), and ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial ...

Magnesium is having a moment. And when it comes to skin care, this mineral could have major benefits. But evidence for transdermal magnesium is limited.

Large cohort study finds TNF inhibitors linked to lower cancer risk in psoriasis, supporting long-term safety of biologic ...

APREMILAST demonstrated sustained efficacy and a consistent safety profile over 52 weeks in paediatric patients with moderate ...

A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab ...

The biopharma’s campaign for the treatment, which received FDA approval late last year to treat HS, aims to help patients get back to daily activities.

Patients with severe psoriasis who were treated with TNFi long-term had a lower risk of developing PsA than those treated with phototherapy.